Endothelial dysfunction in acute coronary syndrome without ST segment elevation in the presence of Helicobacter
Zofia Grabczewska1, Edmund Nartowicz, Ludmiła Szymaniak
1Department of Cardiology and Internal Diseases, Medical Academy, Bydgoszcz, Poland.
Insights
Helicobacter pylori (H. pylori) infection may influence coronary artery disease (CAD) development. Specific H. pylori antigens, not general IgG antibodies, show associations with endothelial dysfunction markers in acute coronary syndrome patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Biology
Background:
- Helicobacter pylori (H. pylori) infection is a common chronic infection.
- The link between H. pylori and atherosclerosis/coronary artery diseases (CAD) requires further clarification.
Purpose of the Study:
- To investigate the association between H. pylori infection and endothelial function in patients diagnosed with acute coronary syndrome (ACS) without ST segment elevation.
Main Methods:
- Evaluated 31 patients (17 males, 14 females) with ACS.
- Measured H. pylori antibodies and endothelial function markers (von Willebrand factor, thrombomodulin, tissue plasmin activator, PAI-1, fibrinogen).
Main Results:
- H. pylori seropositivity was high (93.5%).
- No significant correlation was found between general H. pylori IgG antibodies and endothelial function parameters.
- Specific antibodies to H. pylori p54 protein correlated with vWF (p=0.027).
- Antibodies to H. pylori p33 protein showed a significant association with PAI-1 concentration (p=0.019).
Conclusions:
- The specific H. pylori antigens and corresponding antibodies, rather than general H. pylori IgG presence, may contribute to CAD development.
- Further research is needed to elucidate the role of specific H. pylori antigens in atherosclerosis.
Background:
Helicobacter pylori (H. pylori) infection is one of the most common chronic infections in humans. While a causative relationship between H. pylori infection and several gastrointestinal disorders has been well established, the association between this condition and the development of atherosclerosis and coronary artery diseases (CAD) is less clear.
Aim:
To examine the relationship between H. pylori infection and endothelial function in patients with acute coronary syndrome (ACS) without ST segment elevation.
Methods:
The study group consisted of 31 patients (17 males aged 38-78 years and 14 females aged 45-80 years) with ACS and without ST segment elevation in whom we measured antibodies to H. pylori and haemostatic factors indicating endothelial function, such as von Willebrand factor (vWF), thrombomodulin (TM), tissue plasmin activator (tPA:Ag), tPA inhibitor (PAI-1:Ag) and fibrinogen.
Results:
The proportion of patients with H. pylori seropositivity was 93.5%. No significant relationship between parameters of endothelial function and IgG antibodies to H. pylori were found. There was a significant association between antibodies to p54 protein and vWF (p=0.027) and between antibodies to p33 protein and PAI:Ag concentration (p=0.019).
Conclusions:
These results suggest that the type of H. pylori antigens and antibodies to these antigens rather than the presence of IgG antibodies to H. pylori may play a role in the development of CAD.
Related Concept Videos
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Gastritis II: Pathophysiology


